Galenica AG (LON:0ROG)
101.70
+1.39 (1.38%)
Feb 12, 2026, 4:31 PM GMT
Galenica AG Market Cap
Galenica AG has a market cap or net worth of 4.76 billion as of February 12, 2026. Its market cap has increased by 35.97% in one year.
Market Cap
4.76B
Enterprise Value
5.49B
Revenue
3.70B
Ranking
n/a
PE Ratio
26.95
Stock Price
101.70
Market Cap Chart
Since April 7, 2017, Galenica AG's market cap has increased from 1.72B to 4.76B, an increase of 176.31%. That is a compound annual growth rate of 12.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 4.76B | 4.11% |
| Dec 30, 2025 | 4.57B | 40.01% |
| Dec 30, 2024 | 3.26B | -3.39% |
| Dec 29, 2023 | 3.38B | 0.38% |
| Dec 30, 2022 | 3.37B | 22.40% |
| Dec 30, 2021 | 2.75B | 13.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.90B |
| Convatec Group | 4.29B |
| Hikma Pharmaceuticals | 3.44B |
| Genus | 2.06B |
| HUTCHMED (China) | 1.88B |